Recombinant human parathyroid hormone
Recombinant human parathyroid hormone, sold under the brand names Preotact and Natpara, is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism.[1][2]
Clinical data | |
---|---|
Trade names | Preotact, Natpara |
AHFS/Drugs.com | Monograph |
MedlinePlus | a617013 |
License data | |
Routes of administration | Subcutaneous injection |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
DrugBank | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C408H674N126O126S2 |
Molar mass | 9424.76 g·mol−1 |
References
- "FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". fda.gov. Archived from the original on 30 January 2015. Retrieved 30 January 2015.
- "Natpara Approval History". drugs.com. Retrieved 30 January 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.